Surgical Site Infection Control Market Report Outlook (2022-2033)

Historic Data: 2022-2024   |   Base Year: 2025   |   Forecast Period: 2026-2033
Report Content: Market Scope, Market Segmentation, Market Dynamics, and Competitive Analysis

Report Coverage:
  • Product (Wound Care Dressings, Disinfectants, Clippers, Surgical Gloves, Antiseptics and Disinfectants, Surgical Drapes, Wound Irrigation Products, Others)
  • Type (Superficial Incisional Infection, Deep Incisional Infection, Space Infection)
  • Phase (Preoperative Phase, Intraoperative Phase, Postoperative Phase)
  • End User (Hospitals, Clinics, Ambulatory Surgery Centres, Others)

No. of Pages: 400
Report Code: BMIPUB00032481
Category: Life Sciences
Surgical Site Infection Control Market

The Surgical Site Infection Control Market size is expected to reach US$ 7.78 billion by 2033 from US$ 5.12 billion in 2025. The market is estimated to record a CAGR of 5.37% from 2026 to 2033.

Executive Summary and Global Market Analysis:

Surgical site infection (SSI) control encompasses a range of products and technologies designed to prevent and manage infections at surgical incision sites, including antimicrobial coatings, advanced dressings, sterilization systems, and real-time monitoring tools. These solutions reduce bacterial contamination, promote faster wound healing, and lower healthcare-associated infection rates, which affect up to 5% of surgical procedures globally. SSI control is critical in high-risk surgeries and aligns with global standards like WHO guidelines for safe surgery.

The Surgical Site Infection Control market is experiencing steady growth, primarily driven by the rising incidence of healthcare-associated infections (HAIs), stringent regulatory mandates for infection prevention, and the surge in surgical volumes due to aging populations and chronic conditions like diabetes and obesity. Market expansion is further fueled by post-pandemic emphasis on hospital hygiene, advancements in nanotechnology-based antimicrobials, and increasing adoption of single-use sterile products to minimize cross-contamination.

Surgical Site Infection Control Market - Strategic Insights:

global-market-strategic-framework
Get more information on this report

Surgical Site Infection Control Market Segmentation Analysis:

Key segments that contributed to the derivation of the Surgical Site Infection Control Market analysis are product, type, phase, and end user.

  • By Product, the market is segmented into Wound Care Dressings, Disinfectants, Clippers, Surgical Gloves, Antiseptics and Disinfectants, Surgical Drapes, Wound Irrigation Products, and Others.
  • By Type, the market is segmented into Superficial Incisional Infection, Deep Incisional Infection, and Space Infection.
  • By Phase, the market is segmented into Preoperative Phase, Intraoperative Phase, and Postoperative Phase.
  • By End User, the market is segmented into Hospitals, Clinics, Ambulatory Surgery Centres, and Others.

Surgical Site Infection Control Market Drivers and Opportunities:

Rising Incidence of Surgical Site Infections and HAIs

The paramount driver propelling the Surgical Site Infection Control Market is the escalating global burden of surgical site infections, which affect 2–5% of surgical patients and contribute to over 20% of HAIs, leading to prolonged hospital stays, higher mortality rates, and annual economic costs exceeding US$ 10 billion in the US alone. Regulatory pressures from bodies like the CDC and WHO mandate robust SSI prevention protocols, spurring demand for advanced control solutions. These technologies, such as silver-ion dressings and UV sterilization systems, demonstrably cut infection rates by 30–50%, enabling healthcare facilities to comply with reimbursement policies tied to low HAI metrics while improving patient outcomes and reducing readmissions.

Advancements in Nanotechnology and Smart Monitoring Systems

A significant market opportunity lies in the convergence of nanotechnology applications in wound care; for instance, nanoparticle-containing sutures and dressings, and smart monitoring technology enabled by Internet of Things solutions that offer SSI detection in real-time through biosensors measuring pH, temperature, and biomarkers within the wound environment. This approach launches SSI prevention from a reactive to a proactive approach using AI-driven notifications to facilitate intervention before infection incidents. For high-risk surgeries such as orthopedic and cardiac surgery, these advances have the capability of lowering SSI infection incidents by as much as 60% and entering emerging markets through cheaper and portable technology solutions.

Surgical Site Infection Control Market Size and Share Analysis:

The Surgical Site Infection Control Market demonstrates robust growth, with size and share analysis revealing the strong competitive positioning of established players and the emergence of new technologies. The report further examines subsegments categorized within product, type, phase, and end user, offering insights into their contribution to overall market performance.

For instance, the Wound Care Dressings subsegment dominates the market by product. Their popularity stems from the fact that they are recurring purchases, often disposable or having a limited lifespan, creating a steady and lucrative revenue stream for manufacturers. Hospitals remain the largest end-user segment, driven by the high volume of procedures, the need for advanced infrastructure, and the high initial capital investment required for integrated systems.

Surgical Site Infection Control Market Report Highlights:

Report Attribute Details
Market size in 2025 US$ 5.12 Billion
Market Size by 2033 US$ 7.78 Billion
Global CAGR (2026 - 2033)5.37%
Historical Data 2022-2024
Forecast period 2026-2033
Segments Covered By Product
  • Wound Care Dressings
  • Disinfectants
  • Clippers
  • Surgical Gloves
  • Antiseptics and Disinfectants
  • Surgical Drapes
  • Wound Irrigation Products
  • Others
By Type
  • Superficial Incisional Infection
  • Deep Incisional Infection
  • Space Infection
By Phase
  • Preoperative Phase
  • Intraoperative Phase
  • Postoperative Phase
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centres
  • Others
Regions and Countries Covered
North America US, Canada, Mexico
Europe Belgium, Austria, Finland, Denmark, Greece, Poland, Romania, Russia, Ukraine, Czech Republic, Slovakia, Bulgaria, Italy, Luxembourg, Germany, Switzerland, France, Netherlands, Norway, Portugal, Spain, Sweden, United Kingdom
Asia-Pacific Australia, China, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Bangladesh, New Zealand, Taiwan
South and Central America Brazil, Argentina, Peru, Chile, Colombia
Middle East and Africa Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Turkiye, South Africa, Egypt, Algeria, Nigeria
Market leaders and key company profiles
  • BD
  • 3M
  • PAUL HARTMANN AG
  • Johnson and Johnson
  • Covalon Technologies Ltd.
  • Stryker
  • STERIS plc.
  • Molnlycke Health Care AB
  • DeRoyal Industries
  • Getinge AB
Get more information on this report

Surgical Site Infection Control Market Report Coverage and Deliverables:

The "Surgical Site Infection Control Market Size and Forecast (2022 - 2033)" report provides a detailed analysis of the market covering below areas:

  • Surgical Site Infection Control Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Surgical Site Infection Control Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
  • Surgical Site Infection Control Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Surgical Site Infection Control Market
  • Detailed company profiles, including SWOT analysis

Surgical Site Infection Control Market Geographic Insights:

The geographical scope of the Surgical Site Infection Control Market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America is the dominant region in the Surgical Site Infection Control Market, holding the largest revenue share, owing to advanced healthcare infrastructure, high healthcare expenditure (both public and private), a high concentration of key market players, and the early and widespread adoption of SSI prevention protocols in clinical practice.

Asia Pacific is projected to be the fastest-growing region, driven by rapidly improving healthcare infrastructure, increasing disposable incomes, government initiatives to promote medical technology adoption, a growing patient pool requiring complex surgeries, and increasing medical tourism.

global-market-geography
Get more information on this report

Surgical Site Infection Control Market Research Report Guidance:

  • The report includes qualitative and quantitative data in the Surgical Site Infection Control Market across product, type, phase, end user, and geography.
  • The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the Surgical Site Infection Control Market.
  • Chapter 3 includes the research methodology of the study.
  • Chapter 4 further includes ecosystem analysis.
  • Chapter 5 highlights the major industry dynamics in the Surgical Site Infection Control Market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
  • Chapter 6 discusses the Surgical Site Infection Control Market scenario, in terms of historical market revenues, and forecast till the year 2033.
  • Chapters 7 to 10 cover the Surgical Site Infection Control Market segments by product, type, phase, end user, and geography (including North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America). They cover the market volume, revenue forecast, and factors driving the market.
  • Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
  • Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
  • Chapter 13 provides detailed profiles of the major companies operating in the Surgical Site Infection Control Market. Companies have been profiled on the basis of their key facts, business descriptions, products and services, financial overview, SWOT analysis, and key developments.
  • Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, a list of abbreviations, and a disclaimer.

Surgical Site Infection Control Market News and Key Development:

The Surgical Site Infection Control Market is evaluated by gathering qualitative and quantitative data post-primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the Surgical Site Infection Control Market are:

  • In November 2025, BD, a leading global medical technology company, announced the launch of the BD Surgiphor™ Surgical Wound Irrigation System in Europe. The system is the first of its kind to receive Conformité Européenne (CE) approval and is now available in select European countries. BD Surgiphor™ is a sterile, ready-to-use irrigation solution designed to help loosen and remove debris from surgical wounds during procedures. By flushing out debris and foreign materials, including microorganisms, it helps reduce the bacterial load that could lead to infection.
  • In July 2025, Global MedTech companies Getinge and Zimmer Biomet Holdings, Inc. announced a strategic partnership where Zimmer Biomet will distribute Getinge’s Operating Room (OR) capital products to its Ambulatory Surgery Center (ASC) customers. This partnership creates a turnkey solution for ASC customers, who can now access Getinge’s infection control and surgical portfolio and Zimmer Biomet’s broad menu of best-in-class implants and surgical robotics from a single source.

Key Sources Referred:

  • World Bank - Global Trade Indicators
  • World Trade Organization (WTO)
  • International Monetary Fund (IMF)
  • International Trade Administration (ITA)
  • Company Websites
  • Company Annual Reports
  • Company Investor Presentations
The List of Companies - Surgical Site Infection Control Market
  • BD
  • 3M
  • PAUL HARTMANN AG
  • Johnson and Johnson
  • Covalon Technologies Ltd.
  • Stryker
  • STERIS plc.
  • Molnlycke Health Care AB
  • DeRoyal Industries
  • Getinge AB
Frequently Asked Questions
How big is the Surgical Site Infection Control Market?

The Surgical Site Infection Control Market is valued at US$ 5.12 Billion in 2025, it is projected to reach US$ 7.78 Billion by 2033.

What is the CAGR for Surgical Site Infection Control Market by (2026 - 2033)?

As per our report Surgical Site Infection Control Market, the market size is valued at US$ 5.12 Billion in 2025, projecting it to reach US$ 7.78 Billion by 2033. This translates to a CAGR of approximately 5.37% during the forecast period.

What segments are covered in this report?

The Surgical Site Infection Control Market report typically cover these key segments-

  • Product (Wound Care Dressings, Disinfectants, Clippers, Surgical Gloves, Antiseptics and Disinfectants, Surgical Drapes, Wound Irrigation Products, Others)
  • Type (Superficial Incisional Infection, Deep Incisional Infection, Space Infection)
  • Phase (Preoperative Phase, Intraoperative Phase, Postoperative Phase)
  • End User (Hospitals, Clinics, Ambulatory Surgery Centres, Others)

What is the historic period, base year, and forecast period taken for Surgical Site Infection Control Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Surgical Site Infection Control Market report:

  • Historic Period : 2022-2024
  • Base Year : 2025
  • Forecast Period : 2026-2033
  • Who are the major players in Surgical Site Infection Control Market?

    The Surgical Site Infection Control Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • BD
  • 3M
  • PAUL HARTMANN AG
  • Johnson and Johnson
  • Covalon Technologies Ltd.
  • Stryker
  • STERIS plc.
  • Molnlycke Health Care AB
  • DeRoyal Industries
  • Getinge AB
  • Who should buy this report?

    The Surgical Site Infection Control Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Surgical Site Infection Control Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Sales Assistance
    +1 646 791 7070 (US & UK)
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)